PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Metastatic Urothelial Carcinoma: Maintaining Stable Disease
Visit https://www.peervoice.com/AZJ860 to view the entire programme with slides. After completing “Metastatic Urothelial Carcinoma: Maintaining Stable Disease”, participants will be able to: Describe the latest recommendations for first-line maintenance treatment for patients with stable metastatic urothelial carcinoma (mUC), Interpret the impact of the evidence for maintenance immunotherapy regimens in first-line mUC on treatment sequencing and long-term clinical care of the patient, Identify patients who may be eligible for first-line maintenance treatment with immunotherapy.